Neuronetics, Inc. Common Stock
STIMNeuronetics, Inc. is a medical technology company specializing in developing and commercializing neurostimulation devices for the treatment of mental health and neurological conditions. The company is best known for its NeuroStar Advanced Therapy System, which offers non-invasive transcranial magnetic stimulation (TMS) therapy primarily for the treatment of major depressive disorder. Neuronetics aims to provide innovative solutions that improve patient outcomes and expand access to mental health treatments.
Company News
Neuronetics announced granting inducement awards of restricted stock units (RSUs) to twelve new employees, with vesting schedules contingent on continued employment over three years.
Neuronetics, Inc. has successfully completed the acquisition of Greenbrook TMS Inc. The combined company will continue to operate as Neuronetics, Inc. and the Neuronetics shares will continue to trade on the NASDAQ Global Market under the ticker 'STIM'.
Neuronetics (STIM) announces the nationwide launch of the Better Me Provider (BMP) program developed in collaboration with TMS medical experts. The BMP program will be part of the company's NeuroStar product line.
The first and only TMS company to establish comprehensive standards for patient care and responsiveness in the mental health industry The first and only TMS company to establish comprehensive standards for patient care and responsiveness in the mental health industry
Early prediction of nonresponse abstract selected for oral presentation as a prestigious Top 4 Abstract at CTMSS 2024 Early prediction of nonresponse abstract selected for oral presentation as a prestigious Top 4 Abstract at CTMSS 2024
